These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2126523)

  • 21. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
    Mohan K; Moulin P; Stevenson MM
    J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-γ-induced priming maintains long-term strain-transcending immunity against blood-stage Plasmodium chabaudi malaria.
    da Silva HB; de Salles EM; Panatieri RH; Boscardin SB; Rodríguez-Málaga SM; Alvarez JM; D'Império Lima MR
    J Immunol; 2013 Nov; 191(10):5160-9. PubMed ID: 24133169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD28 costimulation is required for the expression of T-cell-dependent cell-mediated immunity against blood-stage Plasmodium chabaudi malaria parasites.
    Rummel T; Batchelder J; Flaherty P; LaFleur G; Nanavati P; Burns JM; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5768-74. PubMed ID: 15385476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection.
    Stevenson MM; Ghadirian E
    Infect Immun; 1989 Dec; 57(12):3936-9. PubMed ID: 2807555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts.
    Shear HL; Srinivasan R; Nolan T; Ng C
    J Immunol; 1989 Sep; 143(6):2038-44. PubMed ID: 2506274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria.
    Sam H; Stevenson MM
    Clin Exp Immunol; 1999 Aug; 117(2):343-9. PubMed ID: 10444268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice.
    Li C; Corraliza I; Langhorne J
    Infect Immun; 1999 Sep; 67(9):4435-42. PubMed ID: 10456884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma interferon production in endotoxin-responder and -nonresponder mice during infection.
    Freudenberg MA; Kumazawa Y; Meding S; Langhorne J; Galanos C
    Infect Immun; 1991 Oct; 59(10):3484-91. PubMed ID: 1910003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.
    Clark IA; Hunt NH; Butcher GA; Cowden WB
    J Immunol; 1987 Nov; 139(10):3493-6. PubMed ID: 3119710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.
    Singh RP; Kashiwamura S; Rao P; Okamura H; Mukherjee A; Chauhan VS
    J Immunol; 2002 May; 168(9):4674-81. PubMed ID: 11971017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
    Uzonna JE; Kaushik RS; Gordon JR; Tabel H
    J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: lack of a major role for interleukin 1, tumor necrosis factor alpha, and gamma interferon.
    Yap GS; Stevenson MM
    Infect Immun; 1994 Feb; 62(2):357-62. PubMed ID: 8300197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites.
    Taylor PR; Seixas E; Walport MJ; Langhorne J; Botto M
    Infect Immun; 2001 Jun; 69(6):3853-9. PubMed ID: 11349051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.
    De Souza JB; Williamson KH; Otani T; Playfair JH
    Infect Immun; 1997 May; 65(5):1593-8. PubMed ID: 9125535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
    Taylor-Robinson AW; Smith EC
    Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schistosoma mansoni infection cancels the susceptibility to Plasmodium chabaudi through induction of type 1 immune responses in A/J mice.
    Yoshida A; Maruyama H; Kumagai T; Amano T; Kobayashi F; Zhang M; Himeno K; Ohta N
    Int Immunol; 2000 Aug; 12(8):1117-25. PubMed ID: 10917886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria-induced murine pregnancy failure: distinct roles for IFN-gamma and TNF.
    Poovassery JS; Sarr D; Smith G; Nagy T; Moore JM
    J Immunol; 2009 Oct; 183(8):5342-9. PubMed ID: 19783682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
    Kobayashi F; Ishida H; Matsui T; Tsuji M
    J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.